{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:18:32Z","timestamp":1762885112653,"version":"3.45.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25071-3","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:06:45Z","timestamp":1762780005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparison of anthropometric indicators in predicting the incidence of diabetes and intermediate hyperglycaemia in Finland: a 22-year observational study"],"prefix":"10.1186","volume":"25","author":[{"given":"Julia","family":"Lybeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jouko","family":"Saramies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Koiranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Uusitalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirkka","family":"Kein\u00e4nen-Kiukaanniemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadri","family":"Suija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"25071_CR1","unstructured":"World Health Organization. Obesity and overweight. Available from: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Date accessed: September 4, 2023."},{"issue":"1","key":"25071_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12916-017-0901-x","volume":"15","author":"H Kolb","year":"2017","unstructured":"Kolb H, Martin S. Environmental\/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med. 2017;15(1):131. https:\/\/doi.org\/10.1186\/s12916-017-0901-x.","journal-title":"BMC Med"},{"key":"25071_CR3","unstructured":"Centers for Disease Control and Prevention. Diabetes quick facts. Available from: https:\/\/www.cdc.gov\/diabetes\/basics\/quick-facts.html. Date accessed: March 10, 2023."},{"issue":"1","key":"25071_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"MAB Khan","year":"2020","unstructured":"Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al KJ. Epidemiology of Type 2 Diabetes - Global Burden of Disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107\u201311. https:\/\/doi.org\/10.2991\/jegh.k.191028.001.","journal-title":"J Epidemiol Glob Health"},{"key":"25071_CR5","doi-asserted-by":"publisher","first-page":"e067516","DOI":"10.1136\/bmj-2021-067516","volume":"376","author":"A Jayedi","year":"2022","unstructured":"Jayedi A, Soltani S, Motlagh SZ, et al. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ. 2022;376:e067516. https:\/\/doi.org\/10.1136\/bmj-2021-067516.","journal-title":"BMJ"},{"issue":"5","key":"25071_CR6","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3390\/jcm12051876","volume":"12","author":"J Tuomilehto","year":"2023","unstructured":"Tuomilehto J, Uusitupa M, Gregg EW, Lindstr\u00f6m J. Type 2 diabetes prevention programs\u2014from proof-of-concept trials to national intervention and beyond. J Clin Med. 2023;12(5):1876. https:\/\/doi.org\/10.3390\/jcm12051876.","journal-title":"J Clin Med"},{"key":"25071_CR7","doi-asserted-by":"publisher","unstructured":"DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care. 2003;26(3):688\u201396. https:\/\/doi.org\/10.2337\/diacare.26.3.688.","DOI":"10.2337\/diacare.26.3.688"},{"issue":"2","key":"25071_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/s1098-3597(09)60004-1","volume":"8","author":"VA Fonseca","year":"2007","unstructured":"Fonseca VA. Identification and treatment of prediabetes to prevent progression to type 2 diabetes. Clinical Cornerstone. 2007;8(2):10\u20138. https:\/\/doi.org\/10.1016\/s1098-3597(09)60004-1. discussion 19-20.","journal-title":"Clinical Cornerstone."},{"issue":"3","key":"25071_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1467-789x.2001.00031.x","volume":"2","author":"AM Prentice","year":"2001","unstructured":"Prentice AM, Jebb SA. Beyond body mass index. Obes Rev. 2001;2(3):141\u20137. https:\/\/doi.org\/10.1046\/j.1467-789x.2001.00031.x.","journal-title":"Obes Rev"},{"issue":"11","key":"25071_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10654-018-0433-5","volume":"33","author":"DH Lee","year":"2018","unstructured":"Lee DH, Keum N, Hu FB, et al. Comparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and women. Eur J Epidemiol. 2018;33(11):1113\u201323. https:\/\/doi.org\/10.1007\/s10654-018-0433-5.","journal-title":"Eur J Epidemiol"},{"issue":"578","key":"25071_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3399\/bjgp10X515548","volume":"60","author":"S Humphreys","year":"2010","unstructured":"Humphreys S. The unethical use of BMI in contemporary general practice. Br J Gen Pract. 2010;60(578):696\u20137. https:\/\/doi.org\/10.3399\/bjgp10X515548.","journal-title":"Br J Gen Pract"},{"issue":"7","key":"25071_CR12","doi-asserted-by":"publisher","first-page":"E550","DOI":"10.1001\/amajethics.2023.550","volume":"25","author":"KM Flegal","year":"2023","unstructured":"Flegal KM. Use and misuse of BMI categories. AMA J Ethics. 2023;25(7):E550-558. https:\/\/doi.org\/10.1001\/amajethics.2023.550.","journal-title":"AMA J Ethics"},{"key":"25071_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41366-023-01313-5","volume":"47","author":"A Ghulam","year":"2023","unstructured":"Ghulam A, Gianfagna F, Bonaccio M, et al. Association between BMI, RFM and mortality and potential mediators: Prospective findings from the Moli-sani study. Int J Obes. 2023;47:697\u2013708. https:\/\/doi.org\/10.1038\/s41366-023-01313-5.","journal-title":"Int J Obes."},{"key":"25071_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejim.2022.12.024","volume":"109","author":"N Suthahar","year":"2023","unstructured":"Suthahar N, Wang K, Zwartkruis VW, et al. Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population. Eur J Intern Med. 2023;109:73\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2022.12.024.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"25071_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1017\/S0954422410000144","volume":"23","author":"LM Browning","year":"2010","unstructured":"Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247\u201369. https:\/\/doi.org\/10.1017\/S0954422410000144.","journal-title":"Nutr Res Rev."},{"key":"25071_CR16","doi-asserted-by":"publisher","unstructured":"Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity [published correction appears in Lancet Diabetes Endocrinol. 2025;13(3):e6. https:\/\/doi.org\/10.1016\/S2213-8587(25)00006-3. Lancet Diabetes Endocrinol. 2025;13(3):221\u2013262.\u00a0https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4.","DOI":"10.1016\/S2213-8587(25)00006-3"},{"key":"25071_CR17","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41366-019-0516-8","volume":"44","author":"OO Woolcott","year":"2020","unstructured":"Woolcott OO, Bergman RN. Defining cutoffs to diagnose obesity using the relative fat mass (RFM): Association with mortality in NHANES 1999\u20132014. Int J Obes. 2020;44:1301\u201310. https:\/\/doi.org\/10.1038\/s41366-019-0516-8.","journal-title":"Int J Obes"},{"key":"25071_CR18","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1038\/s41598-021-85581-z","volume":"11","author":"T Li","year":"2021","unstructured":"Li T, Quan H, Zhang H, et al. Type 2 diabetes is more predictable in women than men by multiple anthropometric and biochemical measures. Sci Rep. 2021;11:6062. https:\/\/doi.org\/10.1038\/s41598-021-85581-z.","journal-title":"Sci Rep"},{"issue":"6","key":"25071_CR19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.pcd.2021.09.010","volume":"15","author":"J Saramies","year":"2021","unstructured":"Saramies J, Koiranen M, Auvinen J, et al. 22-year trends in dysglycemia and body mass index: A population-based cohort study in Savitaipale. Finland Prim Care Diabetes. 2021;15(6):977\u201384. https:\/\/doi.org\/10.1016\/j.pcd.2021.09.010.","journal-title":"Finland Prim Care Diabetes"},{"key":"25071_CR20","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1038\/s41598-018-29362-1","volume":"8","author":"OO Woolcott","year":"2018","unstructured":"Woolcott OO, Bergman RN. Relative fat mass (RFM) as a new estimator of whole-body fat percentage \u2500 A cross-sectional study in American adult individuals. Sci Rep. 2018;8:10980. https:\/\/doi.org\/10.1038\/s41598-018-29362-1.","journal-title":"Sci Rep"},{"key":"25071_CR21","unstructured":"World Health Organization. Landscape analysis on countries\u2019 readiness to accelerate action to reduce malnutrition. Available from: https:\/\/apps.who.int\/nutrition\/landscape\/help.aspx?menu=0&helpid=420. Date accessed: March 16, 2024."},{"key":"25071_CR22","volume-title":"Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8\u201311 December 2008","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8\u201311 December 2008. Geneva: World Health Organization; 2008. 978 92 4 150149 1."},{"key":"25071_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12916-014-0207-1","volume":"12","author":"M Ashwell","year":"2014","unstructured":"Ashwell M, Gibson S. A proposal for a primary screening tool: `keep your waist circumference to less than half your height\u2019. BMC Med. 2014;12:207. https:\/\/doi.org\/10.1186\/s12916-014-0207-1.","journal-title":"BMC Med"},{"key":"25071_CR24","unstructured":"WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of Diabetes mellitus. Geneva: WHO; 1999. WHO\/MCD\/MCS\/99.2."},{"issue":"3","key":"25071_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275\u201386. https:\/\/doi.org\/10.1111\/j.1467-789X.2011.00952.x.","journal-title":"Obes Rev"},{"issue":"10","key":"25071_CR26","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1007\/s13300-021-01138-3","volume":"12","author":"M Abe","year":"2021","unstructured":"Abe M, Fujii H, Funakoshi S, et al. Comparison of body mass index and waist circumference in the prediction of diabetes: a retrospective longitudinal study. Diabetes Ther. 2021;12(10):2663\u201376. https:\/\/doi.org\/10.1007\/s13300-021-01138-3.","journal-title":"Diabetes Ther"},{"issue":"1","key":"25071_CR27","doi-asserted-by":"publisher","first-page":"e009266","DOI":"10.1136\/bmjopen-2015-009266","volume":"6","author":"S Hartwig","year":"2016","unstructured":"Hartwig S, Kluttig A, Tiller D, et al. Anthropometric markers and their association with incident type 2 diabetes mellitus: which marker is best for prediction? Pooled analysis of four German population-based cohort studies and comparison with a nationwide cohort study. BMJ Open. 2016;6(1):e009266. https:\/\/doi.org\/10.1136\/bmjopen-2015-009266. Published 2016 Jan 20.","journal-title":"BMJ Open."},{"issue":"5","key":"25071_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40608-018-0205-5","volume":"1","author":"M Ghesmaty Sangachin","year":"2018","unstructured":"Ghesmaty Sangachin M, Cavuoto LA, Wang Y. Use of various obesity measurement and classification methods in occupational safety and health research: a systematic review of the literature. BMC Obes. 2018;1(5):28. https:\/\/doi.org\/10.1186\/s40608-018-0205-5.","journal-title":"BMC Obes"},{"key":"25071_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2337\/diacare.26.1.61","volume":"26","author":"DECODE Study Group","year":"2003","unstructured":"DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61\u20139. https:\/\/doi.org\/10.2337\/diacare.26.1.61.","journal-title":"Diabetes Care"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25071-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25071-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25071-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:15:35Z","timestamp":1762884935000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-25071-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25071"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25071-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the Declaration of Helsinki and was approved by the Ethics Review Board of the South Karelia Hospital District. The Research Ethics Committee of the University of Helsinki approved the research (HUS\/2203\/2018).Written informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.T. owns stocks in Orion Pharma, Aktivolabs LTD and Digostics LTD. The other authors declare no potential conflict of interest relevant to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3879"}}